PATH

11/07/2025

Global vaccination rates remain too low, partly due to cold-storage challenges. PATH is helping develop microarray patches—needle-free, heat-stable vaccines that dissolve into the skin.

Easier to transport and use, MAPs could protect 80 million more children by 2040. Early tests show strong support from caregivers and health workers, advancing this breakthrough toward wider use.

PATH: The way to better health.

11/06/2025

is the top cause of severe respiratory infections and hospitalization in infants and young children. 98% of pediatric RSV deaths occur in low- and middle-income economies, and many children never make it to the hospital for care.

"Maternal vaccination offers a vital chance to reduce this burden," says PATH's Clint Pecenka, "protecting babies early and easing the pressure on families and health systems.”

During Week, we outline this year's exciting progress toward introducing maternal RSV vaccines in countries with the greatest burden: https://bit.ly/4qLXjCE

Resvinet Foundation

With new global recommendations in place, countries are poised to take next steps toward introducing maternal RSV vaccines and safeguarding infants from a major health threat.

11/03/2025

The health of people, animals, and our planet has never been more connected. Today, PATH celebrates and the power of multisectoral collaboration to detect threats early, strengthen resilience, and keep communities safe.

From enhancing zoonotic disease detection in Uganda to using climate data for early disease prediction in Vietnam, we’re advancing One Health solutions that protect communities and our shared environment.

Together, we can prevent outbreaks, safeguard ecosystems, and create a healthier future for all.

🔗 Learn how multisectoral action is driving impact: https://bit.ly/437FaoT

11/03/2025

Our Women and Family Health Practice team is excited to be in Bogotá for the International Conference on Family Planning ( )!

Across Latin America and the Caribbean, we partner with ministries of health, civil society, and communities to make care more accessible, equitable, and woman-centered. This looks like:

🌟 Detecting and preventing cancer in Central America through innovative screening, community-based detection models, and digital tracking systems
🌟 Integrating health services and engaging communities through the Unitaid-funded SAFEStart+ initiative for mothers and babies
🌟 Conducting new research to improve access to vaccines for pregnant women
🌟 Giving women more options for family planning—like the Caya diaphragm, a non-hormonal, on-demand contraceptive originally developed by PATH

When women can access care that reflects their lives and choices, entire communities thrive. Throughout the region, we're designing solutions that prioritize choice, control, and dignity.

Learn more: https://bit.ly/4opPGjG

11/01/2025

PATH is a proud sponsor of the 5th International Conference on Family Planning, which kicks off today in Bogotá, Colombia.

At PATH, we champion integrated and primary health care services that center client needs and preferences. With our partners, we promote a rights-based approach to woman-led, integrated service delivery that is essential to the future of family planning programming.

For a full schedule of our events and scientific presentations, visit: https://bit.ly/4p6wojF

10/31/2025

In Africa, complex regulations delay access to lifesaving medicines. PATH supports the African Medicines Agency, which aims to streamline approvals across the continent. By training advocates and helping governments adopt the AMA Treaty, PATH has helped secure signatures from 31 countries—accelerating access to safe, effective, and affordable medicines for millions.

PATH: The way to better health.

10/30/2025

PATH's 2024 Annual Report is live!

From a next-generation polio vaccine to a groundbreaking AI clinical trial, our global teams made incredible progress last year. In fact, in 2024 alone, PATH and its partners reached more than 34 million people with the health products and services they need to thrive. That’s 66 people every minute. 😮

Thank you to the hardworking PATH staff, partners, donors, and community members who make these achievements possible. Your innovation, collaboration, and persistence is changing lives for the better.

Explore the report online: https://bit.ly/4nwbgCa

10/29/2025

6️⃣ years. Countless lives changed.

Since 2019, PATH’s program has grown from focusing on immunization solutions in two countries into a multi-country, multi-health-area force for change. Working side by side with health workers and communities, we’ve designed solutions to some of the hardest challenges, iterated, learned, and scaled.

Explore our progress: https://bit.ly/47hvVoF

10/27/2025

We are so pleased to announce the renewal of our Memorandum of Understanding with Africa CDC.

PATH Chief of Africa Region Dr. Nanthalile Mugala signed the agreement alongside Africa CDC Director General H.E. Dr. Jean Kaseya at the 4th International Conference on Public Health in Africa ( ) in Durban.

This three-year extension reinforces our shared commitment to advancing and strengthening health systems in the African region.

10/24/2025

Polio remains a global threat, especially where low vaccination rates can lead to outbreaks from older vaccines. PATH helped develop a safer, more stable oral vaccine: nOPV2. Over one billion doses have been delivered since 2020, moving the world closer to eradication.

PATH: The way to better health.

10/22/2025

💡 Designing with people, not just for them.

PATH's initiative demonstrates how putting people at the center can transform health systems and outcomes. From rural immunization campaigns in Kenya to job aids in Zambia to AI tools shaped by local providers, this human-centered design approach isn’t just theoretical—it’s saving lives.

Dive into the full Living Labs timeline, impact stories, and stakeholder interviews to see how is reshaping health across geographies: https://bit.ly/497hEvT

10/21/2025

📣 Join us October 29!

New tools for improving detection and treatment of P. vivax malaria are expanding access to radical cure treatment options—but turning innovation into impact requires more than approval.

Supported by an unrestricted educational grant from GSK Global Health, this will spotlight country experiences and global insights on the policies, tools, and systems needed to ensure people can get the care they need.

Register: https://bit.ly/46SoEvb

Featuring speakers from PATH, Menzies School of Health Research, Instituto Leônidas e Maria Deane - Fiocruz Amazônia, World Health Organization (WHO), and Medicines for Malaria Venture (MMV). Simultaneous Portuguese interpretation will be available.